ctDNA and residual cancer burden are prognostic in triple-negative breast cancer patients with residual disease.

Saved in:
Bibliographic Details
Title: ctDNA and residual cancer burden are prognostic in triple-negative breast cancer patients with residual disease.
Authors: Stecklein SR; Department of Radiation Oncology, University of Kansas Medical Center, Kansas City, KS, USA.; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA.; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS, USA.; The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA., Kimler BF; Department of Radiation Oncology, University of Kansas Medical Center, Kansas City, KS, USA., Yoder R; The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA., Schwensen K; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA., Staley JM; The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA., Khan QJ; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA., O'Dea AP; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA., Nye LE; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA., Elia M; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA., Heldstab J; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA., Home T; The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA., Hyter S; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA., Isakova K; The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA., Pathak HB; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA., Godwin AK; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA.; The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA., Sharma P; The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA. psharma2@kumc.edu.; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA. psharma2@kumc.edu.
Source: NPJ breast cancer [NPJ Breast Cancer] 2023 Mar 06; Vol. 9 (1), pp. 10. Date of Electronic Publication: 2023 Mar 06.
Publication Type: Journal Article
Journal Info: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36878909
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: ctDNA and residual cancer burden are prognostic in triple-negative breast cancer patients with residual disease.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Stecklein+SR%22">Stecklein SR</searchLink>; Department of Radiation Oncology, University of Kansas Medical Center, Kansas City, KS, USA.; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA.; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS, USA.; The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22Kimler+BF%22">Kimler BF</searchLink>; Department of Radiation Oncology, University of Kansas Medical Center, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22Yoder+R%22">Yoder R</searchLink>; The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22Schwensen+K%22">Schwensen K</searchLink>; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22Staley+JM%22">Staley JM</searchLink>; The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22Khan+QJ%22">Khan QJ</searchLink>; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22O'Dea+AP%22">O'Dea AP</searchLink>; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22Nye+LE%22">Nye LE</searchLink>; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22Elia+M%22">Elia M</searchLink>; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22Heldstab+J%22">Heldstab J</searchLink>; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22Home+T%22">Home T</searchLink>; The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22Hyter+S%22">Hyter S</searchLink>; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22Isakova+K%22">Isakova K</searchLink>; The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22Pathak+HB%22">Pathak HB</searchLink>; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22Godwin+AK%22">Godwin AK</searchLink>; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA.; The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22Sharma+P%22">Sharma P</searchLink>; The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA. psharma2@kumc.edu.; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA. psharma2@kumc.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101674891%22">NPJ breast cancer</searchLink> [NPJ Breast Cancer] 2023 Mar 06; Vol. 9 (1), pp. 10. <i>Date of Electronic Publication: </i>2023 Mar 06.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Breast+Cancer+Research+Foundation%22">Breast Cancer Research Foundation </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101674891 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2374-4677 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223744677%22">23744677 </searchLink><i>NLM ISO Abbreviation: </i>NPJ Breast Cancer <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36878909
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41523-023-00512-7
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 10
    Titles:
      – TitleFull: ctDNA and residual cancer burden are prognostic in triple-negative breast cancer patients with residual disease.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Stecklein SR
      – PersonEntity:
          Name:
            NameFull: Kimler BF
      – PersonEntity:
          Name:
            NameFull: Yoder R
      – PersonEntity:
          Name:
            NameFull: Schwensen K
      – PersonEntity:
          Name:
            NameFull: Staley JM
      – PersonEntity:
          Name:
            NameFull: Khan QJ
      – PersonEntity:
          Name:
            NameFull: O'Dea AP
      – PersonEntity:
          Name:
            NameFull: Nye LE
      – PersonEntity:
          Name:
            NameFull: Elia M
      – PersonEntity:
          Name:
            NameFull: Heldstab J
      – PersonEntity:
          Name:
            NameFull: Home T
      – PersonEntity:
          Name:
            NameFull: Hyter S
      – PersonEntity:
          Name:
            NameFull: Isakova K
      – PersonEntity:
          Name:
            NameFull: Pathak HB
      – PersonEntity:
          Name:
            NameFull: Godwin AK
      – PersonEntity:
          Name:
            NameFull: Sharma P
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 06
              M: 03
              Text: 2023 Mar 06
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 2374-4677
          Numbering:
            – Type: volume
              Value: 9
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: NPJ breast cancer
              Type: main
ResultId 1